Baio-dx
Baio-dx is a French company specializing in artificial intelligence for microbiology diagnostics. Leveraging a unique patented technology combining lensless digital holography and AI algorithms, Baio-dx offers breakthrough solutions for microbiological and biological applications. Their technology enables fast, highly sensitive, and fully automatable reading of antibiotic susceptibility testing (AST/rAST) from 2 hours, identification of bacteria at species level from 4 hours, and early detection and counting of microcolonies directly on Petri dishes. Founded in January 2022 as a spin-off from CEA and CNRS, Baio-dx is committed to fighting antimicrobial resistance (AMR) by reducing time-to-result for adapted antibiotherapy and increasing productivity for microbiological labs. The company is based in Grenoble, France, and has a team of 15 highly skilled employees, including 7 PhDs.
Baio-dx
Baio-dx is a French company specializing in artificial intelligence for microbiology diagnostics. Leveraging a unique patented technology combining lensless digital holography and AI algorithms, Baio-dx offers breakthrough solutions for microbiological and biological applications. Their technology enables fast, highly sensitive, and fully automatable reading of antibiotic susceptibility testing (AST/rAST) from 2 hours, identification of bacteria at species level from 4 hours, and early detection and counting of microcolonies directly on Petri dishes. Founded in January 2022 as a spin-off from CEA and CNRS, Baio-dx is committed to fighting antimicrobial resistance (AMR) by reducing time-to-result for adapted antibiotherapy and increasing productivity for microbiological labs. The company is based in Grenoble, France, and has a team of 15 highly skilled employees, including 7 PhDs.